MT1H and prostate carcinoma: As observed in HCC and prostate cancer, the formation of the MT1h-GLP complex is critical for the MT1h tumor-suppressive effect, as a mutation in MT1h inhibits GLP binding and abolishes the tumor-suppressive activity of MT1h [158].